Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 3Terminated 2Completed 2Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 56Mucositis 22Polycystic Ovary Syndrome 20Neoplasms 17Sexual Dysfunction, Physiological 15Breast Neoplasms 14Dyspnea 11Head and Neck Neoplasms 10Motor Activity 8Colorectal Neoplasms 8Rectal Neoplasms 6Prostatic Neoplasms 6Diabetes Mellitus 6Stomatitis 5Pain 5Lung Neoplasms 5Constipation 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Obesity, Morbid 4Infertility 4Depression 4Colonic Neoplasms 4Xerostomia 3Weight Loss 3Pulmonary Disease, Chronic Obstructive 3Osteoporosis 3Metabolic Syndrome 3Insulin Resistance 3Heart Failure 3Eczema 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Chemotherapy-induced Peripheral Neuropathy × Other × Clear all
NCT06132776 2024-04-26

The Mamma HiToP Study

Vienna Hospital Association

Phase NA Unknown
160 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡